The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world experience on the efficacy and tolerability of biweekly trifluridine/tipiracil with or without bevacizumab in metastatic colorectal cancer.
 
Choon Seong Ang
No Relationships to Disclose
 
Qin Jian Low
No Relationships to Disclose
 
Carol LF Ho
No Relationships to Disclose
 
Robert John Walsh
No Relationships to Disclose
 
Yugarajah Asokumaran
No Relationships to Disclose
 
Joan RE Choo
No Relationships to Disclose
 
Gloria HJ Chan
No Relationships to Disclose
 
Jingshan Ho
No Relationships to Disclose
 
Yvonne Ang
Consulting or Advisory Role - Pfizer; Roche
 
Hon Lyn Tan
No Relationships to Disclose
 
Wei-Peng Yong
Consulting or Advisory Role - Abbvie/Genentech; Amgen; AstraZeneca; Bristol-Myers Squibb; Ipsen; Novartis
Speakers' Bureau - Bayer; Eisai; Lilly; MSD Oncology; Sanofi/Aventis; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Pfizer
 
Raghav Sundar
Honoraria - AstraZeneca; AstraZeneca; Bristol-Myers Squibb; DKSH; Lilly; MSD; Roche; Taiho Pharmaceutical
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; Merck; MSD; Novartis; Taiho Pharmaceutical
Research Funding - MSD; Paxman
Travel, Accommodations, Expenses - AstraZeneca; Eisai; Roche; Taiho Pharmaceutical
 
Cheng Ean Chee
Honoraria - AstraZeneca; Roche/Genentech
Consulting or Advisory Role - Guardant Health AMEA
Travel, Accommodations, Expenses - Taiho Pharmaceutical